Canadian application, no grantCanada
Metal chelators
CA 2179379 A1 · Owner: Resolution Pharmaceuticals Inc. · Inventors: Goodbody, Anne E.; Pollak, Alfred
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Radionuclide chelating compounds are provided for coupling to targetting molecules such as proteins peptides or antibodies. The, resulting labelled targeting molecules may be used in diagnosis and therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 22, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 22, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 22, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 22, 1994
GrantedNo grant recorded
Term endedDecember 22, 2014
Patent numberCA 2179379 A1
Classification (IPC)C07K7/06 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.